Schisandrin B inhibits epithelial‑mesenchymal transition and stemness of large‑cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‑κB and p38 MAPK signaling pathways.

Li S, Wang H, Ma R, Wang L.

Open source

DOI
10.3892/or.2021.8066
Published
2021-04-28
Container
Oncol Rep
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/or.2021.8066,
  title = {Schisandrin B inhibits epithelial‑mesenchymal transition and stemness of large‑cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‑κB and p38 MAPK signaling pathways.},
  author = {Li S and  Wang H and  Ma R and  Wang L.},
  year = {2021},
  journal = {Oncol Rep},
  doi = {10.3892/or.2021.8066},
  url = {https://doi.org/10.3892/or.2021.8066}
}

RIS

TY  - JOUR
TI  - Schisandrin B inhibits epithelial‑mesenchymal transition and stemness of large‑cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‑κB and p38 MAPK signaling pathways.
AU  - Li S
AU  -  Wang H
AU  -  Ma R
AU  -  Wang L.
PY  - 2021
JO  - Oncol Rep
DO  - 10.3892/or.2021.8066
UR  - https://doi.org/10.3892/or.2021.8066
ER  - 

APA

S, L., H, W., R, M., & L., W. (2021). Schisandrin B inhibits epithelial‑mesenchymal transition and stemness of large‑cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‑κB and p38 MAPK signaling pathways.. Oncol Rep. https://doi.org/10.3892/or.2021.8066

Source records